Aigen Investment Management’s Audentes Therapeutics, Inc BOLD Stock Holding History

Aigen Investment Management’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-6,796	Closed	-$407K	–	1720
2019 Q4	$407K	Buy	+6,796	New	+$255K	0.07%	375

Aigen Investment Management's BOLD Position: Q1 2020 in Review

Aigen Investment Management sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 6,796 shares — an estimated $407K sold.

Aigen Investment Management first reported a position in BOLD in Q4 2019 and held it in 1 quarter. The position peaked at $407K in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

Aigen Investment Management reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
Aigen Investment Management sold 6,796 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $407K.
Aigen Investment Management first reported a position in Audentes Therapeutics, Inc in Q4 2019 and held it in 1 quarter.
Aigen Investment Management's Audentes Therapeutics, Inc position peaked at $407K in Q4 2019.
0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Aigen Investment Management's 13F filing for Q1 2020, filed 8 May 2020.